Is the adrenal cortex a target for gonadotropins?

Trends in Endocrinology and Metabolism

Volumn 19, Issue 7, 2008, Pages 231-238

  Bernichtein, Sophie ^a,c   Alevizaki, Maria ^b   Huhtaniemi, Ilpo ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Evgenidion Hospital   (Greece)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GONADOTROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

ADRENAL CORTEX; ADRENAL CORTEX FUNCTION; ADRENAL GLAND; ADRENAL TUMOR; CARCINOGENESIS; CUSHING SYNDROME; DNA MODIFICATION; GONAD; GONADECTOMY; HORMONE ACTION; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 49849094505     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.06.003     Document Type: Review

References (75)

1. Couzinet B., et al. The postmenopausal ovary is not a major androgen-producing gland. J. Clin. Endocrinol. Metab. 86 (2001) 5060-5066
2. Pabon J.E., et al. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 81 (1996) 2397-2400
3. Lacroix A., et al. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr. Rev. 22 (2001) 75-110
4. Christopoulos S., et al. Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Horm. Res. 64 (2005) 119-131
5. Bourdeau I., et al. Adrenocorticotropic hormone-independent Cushing's syndrome. Curr. Opin. Endocrinol. Diabetes Obes. 14 (2007) 219-225
6. Morohashi K. The ontogenesis of the steroidogenic tissues. Genes Cells 2 (1997) 95-106
7. Keegan C.E., and Hammer G.D. Recent insights into organogenesis of the adrenal cortex. Trends in endocrinology and metabolism. Trends Endocrinol. Metab. 13 (2002) 200-208
8. Hammer G.D., et al. Minireview: transcriptional regulation of adrenocortical development. Endocrinology 146 (2005) 1018-1024
9. Else T., and Hammer G.D. Genetic analysis of adrenal absence: agenesis and aplasia. Trends Endocrinol. Metab. 16 (2005) 458-468
10. O'Shaughnessy P.J., et al. Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology 144 (2003) 3279-3284
11. Val P., et al. Identification of a novel population of adrenal-like cells in the mammalian testis. Dev. Biol. 299 (2006) 250-256
12. Apaja P.M., et al. Expression of the mature luteinizing hormone receptor in rodent urogenital and adrenal tissues is developmentally regulated at a posttranslational level. Endocrinology 146 (2005) 3224-3232
13. Banasiak M.J., and Malek A.R. Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management. Neurosurg. Focus 23 (2007) E13
14. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev. 21 (2000) 245-291
15. Fidler W.J. Ovarian thecal metaplasia in adrenal glands. Am. J. Clin. Pathol. 67 (1977) 318-323
16. Romberger C.F., and Wong T.W. Thecal metaplasia in the adrenal gland of a man with acquired bilateral testicular atrophy. Arch. Pathol. Lab. Med. 113 (1989) 1071-1075
17. Wont T.W., and Warner N.E. Ovarian thecal metaplasia in the adrenal gland. Arch. Pathol. 92 (1971) 319-328
18. Mitani F., et al. The undifferentiated cell zone is a stem cell zone in adult rat adrenal cortex. Biochim. Biophys. Acta 1619 (2003) 317-324
19. Bernichtein S., et al. Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology 149 (2008) 651-661
20. Bielinska M., et al. Gonadectomy-induced adrenocortical neoplasia in domestic ferret (Mustela putorius furo) and laboratory mouse. Vet. Pathol. 43 (2006) 97-117
21. Bielinska M., et al. Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor. Endocrinology 144 (2003) 4123-4133
22. Kataoka Y., et al. Cell proliferation and renewal of mouse adrenal cortex. J. Anat. 188 (1996) 375-381
23. Bielinska M., et al. Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice. Endocrinology 146 (2005) 3975-3984
24. Looyenga B.D., and Hammer G.D. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex. Mol. Endocrinol. 20 (2006) 2848-2863
25. Jabara S., et al. Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J. Clin. Endocrinol. Metab. 88 (2003) 484-492
26. Kaaijk E.M., et al. Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study. Mol. Hum. Reprod. 6 (2000) 443-447
27. Mazzuco T.L., et al. Aberrant Expression of Human Luteinizing Hormone Receptor by Adrenocortical Cells Is Sufficient to Provoke Both Hyperplasia and Cushing's Syndrome Features. J. Clin. Endocrinol. Metab. 91 (2006) 196-203
28. Mazzuco T.L., et al. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 147 (2006) 782-790
29. Matzuk M.M., et al. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8817-8821
30. Kananen K., et al. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene. Mol. Endocrinol. 10 (1996) 1667-1677
31. Rilianawati, et al. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Mol. Endocrinol. 12 (1998) 801-809
32. Kumar T.R., et al. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinology 137 (1996) 4210-4216
33. Beuschlein F., et al. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol. Cell. Biol. 23 (2003) 3951-3964
34. Kananen K., et al. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Endocrinology 138 (1997) 3521-3531
35. Kero J., et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J. Clin. Invest. 105 (2000) 633-641
36. Rulli S.B., et al. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143 (2002) 4084-4095
37. Li X., et al. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142 (2001) 2435-2442
38. Frith C. Lipogenic pigmentation, adrenal cortex, mouse. In: Jones T.C., et al. (Ed). The Endocrine System, ILSI Monographs on Laboratory Animals (1996), Springer-Verlag 458-462
39. Rahman N.A., et al. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4. Mol. Endocrinol. 18 (2004) 2553-2569
40. Thompson G.B., and Young Jr. W.F. Adrenal incidentaloma. Curr. Opin. Oncol. 15 (2003) 84-90
41. Mantero F., et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85 (2000) 637-644
42. Werk Jr. E.E., et al. Testosterone-secreting adrenal adenoma under gonadotropin control. N. Engl. J. Med. 289 (1973) 767-770
43. Pittaway D.E., et al. In vitro on an HCG responsive, testosterone secreting adrenal cortical adenoma. Steroids 22 (1973) 731-745
44. Givens J.R., et al. A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease. J. Clin. Endocrinol. Metab. 41 (1975) 845-853
45. Givens J.R., et al. A gonadotropin-responsive adrenocortical adenoma. J. Clin. Endocrinol. Metab. 38 (1974) 126-133
46. Chelly J., et al. Illegitimate transcription: transcription of any gene in any cell type. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2617-2621
47. Carlson H.E. Human adrenal cortex hyperfunction due to LH/hCG. Mol. Cell. Endocrinol. 269 (2007) 46-50
48. Saner-Amigh K., et al. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 91 (2006) 1136-1142
49. Leinonen P., et al. Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 34 (1991) 31-35
50. Barbosa A.S., et al. Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms. BMC Endocr. Disord. 4 (2004) 3
51. Lacroix A., et al. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N. Engl. J. Med. 341 (1999) 1577-1581
52. Feelders R.A., et al. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J. Clin. Endocrinol. Metab. 88 (2003) 230-237
53. Rao ChV., et al. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biol. Reprod. 71 (2004) 579-587
54. Bugalho M.J., et al. Presence of a Gs alpha mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing's syndrome. Gynecol. Endocrinol. 14 (2000) 50-54
55. Dall'Asta C., et al. Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors: in vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma. Horm. Metab. Res. 36 (2004) 578-583
56. Abdallah M.A., et al. Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. J. Clin. Endocrinol. Metab. 89 (2004) 952-956
57. Vuorenoja S., et al. Targeted therapy for adrenal tumors in transgenic mice through their luteinizing hormone receptor (LHR) by hecate-CGb conjugate. Hormone Dependent Cancer 15 (2008) 635-648
58. Mijnhout G.S., et al. Macronodular adrenocortical hyperplasia in a postmenopausal woman. Neth. J. Med. 62 (2004) 454-455
59. Bertherat J., et al. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J. Clin. Endocrinol. Metab. 90 (2005) 1302-1310
60. Horvath A., et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat. Genet. 38 (2006) 794-800
61. Horvath A., et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res. 66 (2006) 11571-11575
62. Kirschner L.S., et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet. 26 (2000) 89-92
63. Lacroix A., et al. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends in endocrinology and metabolism. Trends Endocrinol. Metab. 15 (2004) 375-382
64. Reznik Y., et al. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clin. Endocrinol. (Oxf.) 61 (2004) 311-319
65. Laughlin G.A., and Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85 (2000) 3561-3568
66. Lasley B.L., et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J. Clin. Endocrinol. Metab. 87 (2002) 3760-3767
67. Alevizaki M., et al. The adrenal gland may be a target of LH action in postmenopausal women. Eur. J. Endocrinol. 154 (2006) 875-881
68. Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 333 (1995) 853-861
69. Banaszewska B., et al. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. Rocz. Akad. Med. Bialymst. 48 (2003) 131-134
70. Tsilchorozidou T., et al. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates. J. Clin. Endocrinol. Metab. 88 (2003) 5907-5913
71. Bachelot A., et al. Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure. J. Clin. Endocrinol. Metab. 90 (2005) 2391-2396
72. Davison S.L., et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab. 90 (2005) 3847-3853
73. Parker Jr. C.R., et al. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. J. Clin. Endocrinol. Metab. 85 (2000) 48-54
74. Piltonen T., et al. Ovarian and adrenal steroid production: regulatory role of LH/HCG. Hum. Reprod. 17 (2002) 620-624
75. Carr M.C. The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 88 (2003) 2404-2411